Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 18:2022:1539203.
doi: 10.1155/2022/1539203. eCollection 2022.

A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, Italy

Affiliations
Case Reports

A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, Italy

Benedetta Zampetti et al. Case Rep Endocrinol. .

Abstract

In this study, we report the management, in Lombardy, Italy, of one patient with Cushing's syndrome due to adrenal adenoma and another one with pheochromocytoma, whose surgeries were deferred owing to the COVID-19 pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Nieman L. K., Biller B. M. K., Findling J. W., et al. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline practice guideline. Journal of Clinical Endocrinology & Metabolism . 2015;100(8):2807–2831. doi: 10.1210/jc.2015-1818. - DOI - PMC - PubMed
    1. Lenders J. W. M., Duh Q.-Y., Eisenhofer G., et al. Endocrine Society. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism . 2014;99(6):1915–1942. doi: 10.1210/jc.2014-1498. - DOI - PubMed
    1. Newell-Price J., Nieman L. K., Reincke M., Tabarin A. Endocrinology in the time of COVID-19: management of Cushing’s syndrome. European Journal of Endocrinology . 2020;183(1):G1–G7. doi: 10.1530/EJE-20-0352. - DOI - PMC - PubMed
    1. Guarnotta V., Ferrigno R., Martino M., et al. Glucocorticoid excess and COVID-19 disease. Reviews in Endocrine & Metabolic Disorders . 2020;22(4):703–714. doi: 10.1007/s11154-020-09598-x. - DOI - PMC - PubMed
    1. Pivonello R., De Leo M., Cozzolino A., Colao A. The treatment of Cushing’s disease. Endocrine Reviews . 2015;36(4):385–486. doi: 10.1210/er.2013-1048. - DOI - PMC - PubMed

Publication types

LinkOut - more resources